SG Americas Securities
NNVC icon

SG Americas Securities’s NanoViricides NNVC Stock Holding History

SG Americas Securities’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-905
Closed -$40K – 2872
2016
Q1 		$40K Buy
+905
New +$35.1K ﹤0.01% 2785

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SG Americas Securities's NNVC Position: Q2 2016 in Review

SG Americas Securities sold out of NanoViricides (NNVC) in Q2 2016, closing a stake of 905 shares — an estimated $40K sold.

SG Americas Securities first reported a position in NNVC in Q1 2016 and held it in 1 quarter. The position peaked at $40K in Q1 2016. 51 funds tracked by Wall St. Rank hold NNVC as of Q2 2016.

  • SG Americas Securities reported no remaining NanoViricides position as of Q2 2016 after selling out during the quarter.
  • SG Americas Securities sold 905 NanoViricides shares in Q2 2016, an estimated $40K.
  • SG Americas Securities first reported a position in NanoViricides in Q1 2016 and held it in 1 quarter.
  • SG Americas Securities's NanoViricides position peaked at $40K in Q1 2016.
  • 51 funds tracked by Wall St. Rank held NanoViricides as of Q2 2016.

Based on SG Americas Securities's 13F filing for Q2 2016, filed 3 Aug 2016.